AstraZeneca Pharmaceuticals (AstraZeneca US), a subsidiary of UK-based global drugmaker AstraZeneca, is a significant player in the US pharmaceuticals market. The company's sales represent about a third of its parent's revenues. AstraZeneca US' treatments focus on several therapeutic areas: cardiovascular, renal, metabolic, oncology, and respiratory disorders. Its best-known products include asthma medicine Symbicort; cancer drugs Tagrisso, Faslodex, and Imfinzi; and cardiovascular treatments Brilinta and Farxiga (cardiovascular). The company operates several R&D and manufacturing locations across the US.
See detailed business credit reports on other businesses or your own.
See detailed profiles for insights and prospects on this company's top competitors.
Essential information for a successful call
EMPLOYEES (This Site)
EMPLOYEES (All Sites)
REVENUE (MIL USD)
- Incorporated 1998
Get in Touch with 338 Contacts and 7 Principals*
Pascal SoriotChief Executive Officer
ANTHONY P ZOOKPartner and President
DAVID V ELKINSPartner and Vice President and Chief Financial Officer
GLENN M ENGELMANNPartner and Vice President and Counsel